[Is a further editorial on coxibs needed?]

Presse Med. 2005 Jun 4;34(10):699-700. doi: 10.1016/s0755-4982(05)84021-7.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases / chemically induced
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / pharmacology
  • Drug Industry
  • Humans
  • Risk Factors

Substances

  • Cyclooxygenase Inhibitors